title: Influence of two common polymorphisms in the EPHX1 gene on warfarin maintenance dosage: a meta-analysis.
abstract: We conducted a meta-analysis to investigate the influence of two common single nucleotide polymorphisms (SNPs) (rs2292566 G>A and rs4653436 A>G) in the EPHX1 gene on warfarin maintenance dosages. Relevant literatures were searched using the PubMed, Embase, Web of Science, Cochrane Library, CISCOM, CINAHL, Google Scholar, CBM, and CNKI databases without any language restrictions. STATA Version 12.0 software (Stata Corporation, College Station, TX, USA) was used for this meta-analysis. Standard mean difference and its corresponding 95% confidence interval (95% CI) were calculated. Seven studies met the inclusion criteria, including 2,063 warfarin-treated patients. Meta-analysis results illustrated that EPHX1 rs2292566 G>A polymorphism might be strongly correlated with a higher maintenance dose of warfarin. However, no interaction of EPHX1 rs4653436 A>G polymorphism with warfarin maintenance dosage was detected. A further subgroup analysis based on stratification by ethnicity indicated that EPHX1 rs2292566 G>A polymorphism was positively correlated with warfarin maintenance dosage among Caucasians, but not Asians. No associations were observed between EPHX1 rs4653436 A>G polymorphism warfarin maintenance dosage among both Caucasians and Asians. Our meta-analysis provides robust and unambiguous evidence that EPHX1 rs2292566 polymorphism may affect the maintenance dose of warfarin in Caucasians.
authors: Department of Pharmacy, Jining No. 1 People's Hospital, Jining 272011, China.
authors: Hong-Qiang
authors: HQ
authors: Liu
authors: Jining Hospital of Traditional Chinese Medicine, Jining 272137, China.
authors: Chang-Po
authors: CP
authors: Zhang
authors: Jining Municipal Authority Hospital, Jining, Shandong 272000, China.
authors: Chang-Zhen
authors: CZ
authors: Zhang
authors: Department of Pharmacy, Jining No. 1 People's Hospital, Jining 272011, China.
authors: Xiang-Chen
authors: XC
authors: Liu
authors: Jining Municipal Authority Hospital, Jining, Shandong 272000, China ; Department of Neurology, China-Japan Friendship Hospital, Yinghua Road No. 2, Chaoyang District, Beijing 100029, China.
authors: Zun-Jing
authors: ZJ
authors: Liu
mesh_terms: D030541:Databases, Genetic; D004305:Dose-Response Relationship, Drug; D004851:Epoxide Hydrolases / Q000235:genetics*; D006801:Humans; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D017594:Publication Bias; D016896:Treatment Outcome; D014859:Warfarin / Q000494:pharmacology*
chemical_list: D014859:Warfarin; D004851:Epoxide Hydrolases; C522330:EPHX1 protein, human
references: Ann Intern Med. 1994 Apr 1;120(7):552-8
references: 8116992
references: Arterioscler Thromb Vasc Biol. 2001 Oct;21(10):1668-73
references: 11597943
references: Genet Epidemiol. 2005 Feb;28(2):123-37
references: 15593093
references: J Intern Med. 2005 Mar;257(3):209-23
references: 15715678
references: Clin Pharmacol Ther. 2005 May;77(5):365-72
references: 15900282
references: Bioinformatics. 2005 Sep 15;21(18):3672-3
references: 15955784
references: Hum Genet. 2005 Nov;118(2):287-94
references: 16184405
references: JAMA. 2006 Feb 8;295(6):676-80
references: 16467236
references: Thromb Haemost. 2006 Feb;95(2):205-11
references: 16493479
references: Atherosclerosis. 2006 May;186(1):74-9
references: 16125711
references: Hum Genet. 2007 Mar;121(1):23-34
references: 17048007
references: Pharmacogenomics J. 2007 Apr;7(2):99-111
references: 16983400
references: Vitam Horm. 2008;78:35-62
references: 18374189
references: Pharmacogenomics. 2009 Dec;10(12):1905-13
references: 19958090
references: Clin Pharmacol Ther. 2010 Jan;87(1):57-64
references: 19794411
references: Clin Pharmacol Ther. 2010 Apr;87(4):459-64
references: 20072124
references: Eur J Epidemiol. 2010 Sep;25(9):603-5
references: 20652370
references: J Thromb Thrombolysis. 2010 Oct;30(3):358-64
references: 20499136
references: J Cardiovasc Electrophysiol. 2010 Nov;21(11):1260-5
references: 20586826
references: Eur J Clin Pharmacol. 2010 Dec;66(12):1217-27
references: 20842355
references: Mol Biol Rep. 2011 Jan;38(1):495-501
references: 20376705
references: Pharmacogenet Genomics. 2011 Jan;21(1):35-41
references: 21192345
references: J Thromb Thrombolysis. 2011 Apr;31(3):326-43
references: 21359645
references: Clin Pharmacol Ther. 2011 Jun;89(6):791; author reply 792
references: 21593757
references: Pediatr Hematol Oncol. 2011 Aug;28(5):425-7
references: 21615247
references: Br J Haematol. 2011 Aug;154(3):311-24
references: 21671894
references: Blood. 2011 Sep 15;118(11):3163-71
references: 21725053
references: Thromb Res. 2011 Oct;128(4):331-4
references: 21620442
references: Blood. 2011 Nov 3;118(18):4992-9
references: 21890644
references: J Thromb Haemost. 2003 Aug;1(8):1718-23
references: 12911583
references: Clin Chem Lab Med. 2004 Mar;42(3):294-9
references: 15080562
references: Circulation. 2011 Dec 6;124(23):2554-9
references: 22144632
references: Arch Toxicol. 2012 Mar;86(3):431-9
references: 21983886
references: Lancet Neurol. 2012 Apr;11(4):315-22
references: 22402056
references: Am J Cardiol. 2012 Aug 1;110(3):453-60
references: 22537354
references: Basic Clin Pharmacol Toxicol. 2013 Mar;112(3):209-14
references: 23061746
references: Mol Carcinog. 2013 Aug;52(8):619-26
references: 22415791
references: Tumour Biol. 2013 Aug;34(4):2383-8
references: 23681797
references: Genet Test Mol Biomarkers. 2013 Dec;17(12):932-6
references: 23941071
references: Mol Diagn Ther. 2014 Feb;18(1):73-83
references: 24092646
references: Heart. 2000 Nov;84(5):548-52
references: 11040019
references: Cytogenet Cell Genet. 1998;83(1-2):44-5
references: 9925921